Investigating antidiabetic drug targets as potential therapeutic modulators for schizophrenia
Antidiabetic drugs may possess therapeutic potential in schizophrenia by modulating specific drug-related pathways.These findings provide new theoretical support for the selection of ADs in patients with schizophrenia comorbid with diabetes, and also offer new insights for the future development of APs.
Authors
- Xu Lin (ORCID: https://orcid.org/0009-0007-4097-2006)
- Yajuan Xu
- Gui-Bing Chen (ORCID: https://orcid.org/0009-0005-0100-7284)
- Yu-Sheng Huang (ORCID: https://orcid.org/0009-0001-8436-3604)
Institutions
- Fujian Medical University (CN)
- 174th hospital of the People's Liberation Army (CN)
Publication Details
- Journal
- Psychopharmacology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1007/s00213-025-06951-3
- Primary Topic
- Phosphodiesterase function and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00